← Eichor
Condition: Squamous Cell Carcinoma Scc Of The Oral Cavity Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Squamous Cell Carcinoma Scc Of The Oral Cavity

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
NA · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT07180901Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · 153 location(s) · NRG Oncology · NCT06532279Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative
NA · 3 location(s) · Tata Memorial Hospital · NCT05774483Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Phase N/A · 1 location(s) · Viome · NCT05451303BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or S
Phase 2 · 225 location(s) · National Cancer Institute (NCI) · NCT05136196Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell
Phase N/A · 19 location(s) · AO Innovation Translation Center · NCT04098146Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
Phase 2 · 1 location(s) · Case Comprehensive Cancer Center · NCT06627270Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squ
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06448026Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel
Phase N/A · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT06947668Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Phase 1 · 18 location(s) · National Cancer Institute (NCI) · NCT05172245Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma
Phase 3 · 1 location(s) · Qunxing Li,MD · NCT07371611Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer
Phase 2 · 1 location(s) · Erasmus Medical Center · NCT04191460Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer
Phase 2 · 3 location(s) · Olgun Elicin · NCT07058805Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage
Phase 2 · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT02290145Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.
NA · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05719779Tirilizumab with Albumin-bound Paclitaxel and Cisplatin for Locally Advanced Resectable Oral Squamous Cell Carcinoma
Phase 2 · 1 location(s) · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao · NCT06470217Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy
NA · 1 location(s) · Jessica Mezzanotte Sharpe · NCT07555210Neoadjuvant Immunochemotherapy for LAOSCC
Phase 3 · 1 location(s) · Lai-ping Zhong · NCT06258811Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
NA · 1 location(s) · Alpha Tau Medical LTD. · NCT03889899A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPS
Phase N/A · 1 location(s) · Zhujiang Hospital · NCT07133958High-Resolution PET-CT Imaging for Surgical Margin Visualization
NA · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT06915454Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Phase 2 · 100 location(s) · National Cancer Institute (NCI) · NCT07195734Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squa
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT05098119Surgeon-performed Ultrasound for Real-time Guidance In Oral Cancer Surgeries - A Multicenter Randomized Controlled Trial
NA · 7 location(s) · Tobias Todsen · NCT07203911"Ultra-High Frequency intraOral UltraSonography of the TONgue" (HOUSTON)
NA · 1 location(s) · University of Pisa · NCT06336941A Study on Tumor Budding Guiding Individualized Surgical Planning of Early-stage Oral Squamous Cell Carcinoma.
NA · 1 location(s) · Jinsong Hou · NCT02743832Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology
Phase N/A · 5 location(s) · Memorial Sloan Kettering Cancer Center · NCT02507141Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
Phase 1 · 1 location(s) · VLP Therapeutics · NCT06736379Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cel
Phase 2 · 1 location(s) · University of Michigan Rogel Cancer Center · NCT07121595SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography
Phase N/A · 1 location(s) · University of Palermo · NCT06321003
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.